Although we take the Government’s state of emergency seriously, in order not to pause our first cancer screening test N-NOSE completely, we continue the analysis in our analysis center and three R&D centers while taking necessary steps to prevent infection.
To support our employees to cope with the situation, we have decided to reward them with lump-sum payments (JPY 30,000 per employee).
We will continue to focus on our efforts to expand N-NOSE tests so that we can provide it for as many people as possible.
We are pleased to inform you that HoriPro Inc. has entered into a capital and business alliance agreement to popularize N-NOSE®. Under this agre . . .2021.02.24
A special plan "N-NOSE® Health Support Plus" with "Harmek Health Support" provided by Halmek Ventures, Inc. added our nematode cancer test "N-NO . . .2021.02.24
We are focusing on building a system that allows cancer tests to be performed with peace of mind even in the case of corona, and we are launchin . . .2021.02.22